Dabigatran versus warfarin after bioprosthesis valve replacement for the management of atrial fibrillation postoperatively: protocol.
Andre Rodrigues DuraesPollianna Ds RorizFabio V BulhoesBianca DA NunesJuliana Qv MunizItalvar Ndcr NetoAndre Ms FernandesFrancisco Jfbd ReisEdmundo Jn CamaraErenaldo Dsr JuniorDeusdeth Ts SegundoFelipe Pinho E Albuquerque SilvaRoque ArasPublished in: JMIR research protocols (2014)
Clinicaltrials.gov NCT01868243; http://clinicaltrials.gov/ct2/show/NCT01868243 (Archived by WebCite at http://www.webcitation/6OABiuasd).
Keyphrases
- atrial fibrillation
- aortic valve
- oral anticoagulants
- direct oral anticoagulants
- catheter ablation
- left atrial
- left atrial appendage
- aortic valve replacement
- transcatheter aortic valve implantation
- aortic stenosis
- transcatheter aortic valve replacement
- randomized controlled trial
- computed tomography
- heart failure
- image quality
- mitral valve
- dual energy
- contrast enhanced
- percutaneous coronary intervention
- positron emission tomography
- magnetic resonance imaging
- venous thromboembolism
- left ventricular
- magnetic resonance
- pet ct